Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio (QoQ) (2020 - 2026)
Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zentalis Pharmaceuticals | 312.67 Mn | 312.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.98% |
| Dec 31, 2025 | -149,381.71% |
| Sep 30, 2025 | -259.96% |
| Jun 30, 2025 | 18.49% |
| Mar 31, 2025 | -284.11% |
| Dec 31, 2024 | 92.69% |
| Sep 30, 2024 | -169.74% |
| Jun 30, 2024 | -173.12% |
| Mar 31, 2024 | 96.47% |
| Dec 31, 2023 | -1,056.41% |
| Sep 30, 2023 | 38.14% |
| Jun 30, 2023 | 43.50% |
| Sep 30, 2022 | 92.18% |
| Jun 30, 2022 | -9.64% |
| Sep 30, 2021 | -47.07% |
| Jun 30, 2021 | -53.74% |
| Mar 31, 2021 | -4,184.19% |
| Dec 31, 2020 | 95.58% |
| Sep 30, 2020 | -42.13% |
| Jun 30, 2020 | -84.51% |